For the best experience of the website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.    
Community Engagement

Community Engagement Panel - seeking expressions of interest

ATIC is seeking expressions of interest from those with first-hand experience of type 1 diabetes to join our community engagement panel.

Find out more
Our domains

What does ATIC do?

ATIC is working across six distinct interconnected Domains to ensure maximum impact and fulfil our bold vision.
Get involved

New immunotherapy trial making an IMPACT

ATIC researchers are trialling a new medication called IMCY-0098 to see whether it preserves pancreas function by dampening the immune attack on insulin-producing cells that occurs in people with type 1 diabetes.

Are you eligible to participate?

Learn More
News & Events

News

Community Engagement Panel – calling for expressions of interest

November 2022

ATIC is seeking expressions of interest from members of the type 1 diabetes community who are interested in joining our Community Engagement Panel.


Events

Benchmarking cells for beta cell replacement therapies

October 2022

3rd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series


Events

Harnessing T cell exhaustion to treat autoimmune disease

September 2022

2nd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series


Events

New ATIC Seminar Series: commencing 26th August 2022

August 2022

Introducing ATIC’s new seminar series ‘Beyond Insulin: Innovative research in T1D prevention and cure’. Join us for a new session each month!


Partnerships

We partner with global leaders in our field

Supported by
Coordinating Centre